New patent for Novo Nordisk drug XULTOPHY 100/3.6

Annual Drug Patent Expirations for XULTOPHY+100%2F3.6 Xultophy 100/3.6 is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are…

The post New patent for Novo Nordisk drug XULTOPHY 100/3.6 appeared first on DrugPatentWatch Blog.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: